Board of Directors & 


Our Board of Directors


John "Jay" Schwartz PhD
Mark Grinstaff
Board Member
Eyal S. Ron
Board Member
Karen English CPA MBA
Board Member

Peter Lui
Board Member

AcuityBio has assembled a world-class advisory team of industry experts.

Benedict Daly MD

 Dr. Daly is the Clinical Director of General Thoracic Surgery at the Boston University School of Medicine. He is a board certified Thoracic Surgeon and specializes in Tumors of the Lung, Esophagus, Mediastinum, Chest Wall and Diaphragm; Benign Disorders of the Esophagus including Gastroesophageal Reflux Disease; Thoracoscopic Surgery; Laser Bronchoscopy, tracheobronchial Stents, and Brachytherapy.

Philip Linden MD

Dr. Linden is the Chief of the Division of Thoracic Surgery at Case Western Medical Center/University Hospitals. He is a board certified Thoracic Surgeon and specializes in Minimally Invasive (VATS) Lung and Esophageal Surgery, Thoracic Oncology, High Risk Chest Surgery, and Lung Cancer In the Emphysema Patient

Michael Rabin MD
Dr. Rabin is the Clinical Director of the Lowe Center for Thoracic Oncology at the Dana Farber Cancer Institute, and Assistant Professor of Medicine at the Harvard Medical School, Brigham and Women's Hospital. He is a clinical oncologist specializing in lung cancer and mesothelioma..
Steven Schwaitzberg MD

Dr. Schwaitzberg is the Chair of the University at Buffalo's Department of Surgery. In addition, he is the former Chief of Surgery at the Cambridge Health Alliance, an advisor to the FDA, and President-elect of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). He is a Gastrointestinal and Endocrine Surgeon specializing Laparoscopic Cholecystectomy/Bile Duct Exploration, Laparoscopic Colon Resection, Laparoscopic Distal Pancreatectomy/Splenectomy, Laparoscopic Adrenalectomy, Laparoscopic Gastrointestinal Procedures, Thyroid Lobectomy, Thyroidectomy, Lymph Node Biopsy, and clinical trials.

Arthur Rosenthal PhD

Emeritus Professor of Practice, Biomedical Engineering. Boston Scientific -former CSO, ex- J&J, CR Bard, Kendall; 3M; Homedica, Inc, CEO Cappella, Inc,, CoFounder, gEyeCue Medical Systems, Ltd.

Eyal Ron PhD

 Dr. Ron has over 20 years of experience in the development of drugs, biomaterials, and drug delivery systems. He developed and commercialized Gliadel®, InFuse®, ProLease®..

Candida Fratazzi MD

Orphan drug clinical and regulatory strategy and trail design specialist with more than 25 years of research experience, approval of Velaglucerase alpha (Shire), Replagal (Shire), Lipoprotamase (Alnara), and Tigecycline (Wyeth)